The largest database of trusted experimental protocols

4 protocols using tlrl pelps

1

Monocyte Stimulation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For stimulation assays, 4 × 105 monocytes were exposed to ultrapure LPS (20 ng/ml) (catalog # tlrl-pelps, Invivogen) for either 2 or 24 hours. Alternatively, monocytes were exposed to IFNγ (catalog # 285-IF, R&D Systems) at a concentration of 20 ng/ml for 24 hours. The number of treated samples per individual depended on the total number of cells purified, and the priority on sample accrual was collation of IFNγ-treated followed by 24-hour LPS and then 2-hour LPS, respectively. Experiments were terminated simultaneously, ensuring identical incubation periods for all samples. A subset of samples was kept in the incubator without stimulation throughout this period to ascertain incubator effects. All experiments were completed within 48 hours of blood sample collection.
+ Open protocol
+ Expand
2

Inflammasome Activation and Lipid Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipopolysaccharide (LPS) (Escherichia coli; tlrl-pelps) and flagellin (Salmonella typhimurium; tlrl-stfla) were from Invivogen (San Diego, CA, USA). Adenosine triphosphate (ATP) (A2383), while nigericin (N7143), poly(dA:dT) (P0883), and PF-04620110 (PZ0207) were from Sigma-Aldrich (St. Louis, MO, USA). The following antibodies were used: polyclonal rabbit anti-caspase-1 for mouse caspase-1 (1:1,000) (SC-514; Santa Cruz Biotechnology, Dallas, TX, USA), polyclonal goat anti-IL-1β for mouse IL-1β (1:1,000) (AF-401-NA; R&D Systems, Minneapolis, MN, USA), polyclonal rabbit anti-ASC for mouse ASC (1:1,000) (ADI-905-173-100; Enzo Lifesciences, Farmingdale, NY, USA), polyclonal rabbit anti-DGAT1 for mouse DGAT1 (1:1,000) (ab54037; Abcam, Cambridge, MA, USA), and monoclonal mouse anti-β-actin (1:5,000) (A5316; Sigma-Aldrich).
+ Open protocol
+ Expand
3

Profiling Cytokine Responses to TLR Ligands

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 96-well plates and stimulated at 80% confluence with or without specific TLR ligands in 100 µl culture medium (triplicates); Pam3CysSerLys4 (P3CSK4; TLR2/1 ligand, 100 ng/ml, #L2000, EMCmicrocollection GmbH, Tübingen, Germany), Pam2CGDPKHPKSF (FSL-1; TLR2/6 ligand, 50 ng/ml, #L7000, EMCmicrocollection GmbH), polyinosinic:polycytidylic acid (poly (I:C); TLR3 ligand, 50 μg/ml, #27-4729-01, Amersham Pharmacia Biotech, Uppsala, Sweden), E. coli lipopolysaccharide (LPS) (TLR4 ligand, 100 ng/ml, #tlrl-pelps, InvivoGen, San Diego, CA), flagellin (TLR5 ligand, 1 μg/ml, #tlrl-stfla, InvivoGen), R848 (TLR7/TLR8 ligand, 1 μg/ml, #tlr-r848-5, InvivoGen), and CpG oligodeoxynucleotide (ODN) 2006 (TLR9 ligand, 20 μM, TIBMolBiol, Berlin, Germany). LPS was sonicated for 5 min prior to use. After 24 h supernatants were collected, centrifuged, and stored at -80 C°.
For quantification of cytokine responses, supernatants were thawed on ice and analyzed with a human 10-plex cytokine immunoassay (Bio-Rad) on a Bio-Plex 200 system (Bio-Rad) powered by Luminex xMAP Technology. The levels of IL-1β, IL-6, IL-8, IL-9, IL-10, IL-12 (p70), interferon-(IFN)-γ inducible protein (IP)-10, tumor necrosis factor (TNF)-α, IFN-γ, and vascular endothelial growth factor A (VEGF-A) were measured.
+ Open protocol
+ Expand
4

Functional Immune Response Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected between 9 and 10 A.M. after an overnight fast lasting at least 12 hours. Functional immune responses were assessed in vitro using a well-established LPS challenge protocol that reliably induces pro-inflammatory cytokine production [36] . Whole blood samples were cultured on RPMI Medium 1640 (1x) with L-Glutamine, Cat# 11875-093 (Invitrogen, Waltham, MA) for 6 hours at 37°C in a 5% CO2 tissue culture incubator under three conditions: in the presence of LPS alone, in the presence of LPS and the β₂-agonist CBL, and in the absence of both LPS and CBL (i.e. Control condition). Specifically, LPS-EB Ultrapure 5mg, 5 × 10 6 EU/ml, Cat# tlrl-pelps (InvivoGen, San Diego, CA) with working concentration of 0.1 μg/mL and Clenbuterol hydrochloride, Cat# C5423-10MG (MilliporeSigma, St. Louis, MO) with working concentration of 10 -6 M were used. After 6 hours of incubation, the cultured whole blood samples were centrifuged. Supernatant was collected and stored at -20°C.
Comprehensive details on sample collection, storage, dose determination of LPS and CBL, as well as experimental environment can be found in Supplementary Methods -SM1. Additionally, details of secondary analyses to determine if storage time affected immune protein levels within our sample were reported in Supplementary Methods -SM2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!